Breakthrough in cachexia treatment through a novel selective androgen receptor modulator?!

door Thum, Thomas, Springer, Jochen
Gepubliceerd in 2011

Evidence for an effect of ACE inhibitors on cancer cachexia

door Schanze, Nancy, Springer, Jochen
Gepubliceerd in 2012

Bile acids for cachexia therapy: Reply to the letter by Shailendra Kapoor: Ursodeoxycholic acid and its emerging role in attenuation of tumor growth in gastrointestinal malignancie...

door Tschirner, Anika, Springer, Jochen
Gepubliceerd in 2012

MicroRNAs in muscle wasting

door Suzuki, Tsuyoshi, Springer, Jochen
Gepubliceerd in J Cachexia Sarcopenia Muscle (2019)

Biomarkers for cancer cachexia: where do we stand?

door Palus, Sandra, Springer, Jochen
Gepubliceerd in J Cachexia Sarcopenia Muscle (2020)

Physical activity for the prevention and treatment of sarcopenic obesity

door Saitoh, Masakazu, Ishida, Junichi, Springer, Jochen
Gepubliceerd in J Cachexia Sarcopenia Muscle (2017)

Single‐nucleotide polymorphisms in cachexia‐related genes: Can they optimize the treatment of cancer cachexia?

door Ishida, Junichi, Saitoh, Masakazu, Springer, Jochen
Gepubliceerd in J Cachexia Sarcopenia Muscle (2017)

Is cardiac wasting accompanied by skeletal muscle loss in breast cancer patients receiving anticancer treatment?

door Ishida, Junichi, Saitoh, Masakazu, Springer, Jochen
Gepubliceerd in J Cachexia Sarcopenia Muscle (2017)

Considering technique of assessment and method for normalizing skeletal muscle mass

door Saitoh, Masakazu, Ishida, Junichi, Springer, Jochen
Gepubliceerd in J Cachexia Sarcopenia Muscle (2017)

Skeletal muscle wasting in chronic heart failure

door Suzuki, Tsuyoshi, Palus, Sandra, Springer, Jochen
Gepubliceerd in ESC Heart Fail (2018)

Muscle Wasting and Sarcopenia in Heart Failure—The Current State of Science

door Lena, Alessia, Anker, Markus S., Springer, Jochen
Gepubliceerd in Int J Mol Sci (2020)

Muscle wasting: an overview of recent developments in basic research

door Palus, Sandra, von Haehling, Stephan, Springer, Jochen
Gepubliceerd in 2014

Blocking myostatin: muscle mass equals muscle strength?

door Anker, Markus S., von Haehling, Stephan, Springer, Jochen
Gepubliceerd in J Cachexia Sarcopenia Muscle (2020)

Loss of muscle mass: current developments in cachexia and sarcopenia focused on biomarkers and treatment

door Drescher, Cathleen, Konishi, Masaaki, Ebner, Nicole, Springer, Jochen
Gepubliceerd in J Cachexia Sarcopenia Muscle (2015)

Hypermetabolism: should cancer types, pathological stages and races be considered in assessing metabolism and could elevated resting energy expenditure be the therapeutic target in...

door Ishida, Junichi, Konishi, Masaaki, Saito, Masakazu, Springer, Jochen
Gepubliceerd in J Cachexia Sarcopenia Muscle (2015)

Concern regarding quality and quality of muscle

door Saitoh, Masakazu, Ishida, Junichi, Konishi, Masaaki, Springer, Jochen
Gepubliceerd in J Cachexia Sarcopenia Muscle (2015)

Irisin – a myokine potentially bridging muscle and fat tissue in cachexia

door Konishi, Masaaki, Ishida, Junichi, Saito, Masakazu, Springer, Jochen
Gepubliceerd in J Cachexia Sarcopenia Muscle (2015)

The concept that focuses on oral motor and feeding function in cancer patients with muscle wasting: Skeletal muscle mass is associated with severe dysphagia in cancer patients

door Saitoh, Masakazu, Ishida, Junichi, Konishi, Masaaki, Springer, Jochen
Gepubliceerd in J Cachexia Sarcopenia Muscle (2016)

Growth differentiation factor‐15 as a prognostic biomarker in cancer patients

door Ishida, Junichi, Konishi, Masaaki, Saitoh, Masakazu, Springer, Jochen
Gepubliceerd in J Cachexia Sarcopenia Muscle (2016)

Clinical perspective for wasting in diaphragm, an ever‐trained muscle

door Konishi, Masaaki, Ishida, Junichi, Saitoh, Masakazu, Springer, Jochen
Gepubliceerd in J Cachexia Sarcopenia Muscle (2016)